Cargando…
Monitoring Endocrine Complications of Immunotherapy: A Screening Tool
Introduction The advent of immunotherapy has revolutionized cancer therapy in recent years. Immunotherapy using monoclonal antibodies against checkpoint molecules, including programmed death (PD)-1, PD ligand (PD-L)1, and cytotoxic T-lymphocyte antigen 4 (CTLA)-4, has become a cornerstone in cancer...
Autores principales: | Majety, Priyanka, Groysman, Anna, Seery, Virginia, Shea, Meghan, Hou, Runhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375107/ https://www.ncbi.nlm.nih.gov/pubmed/35974849 http://dx.doi.org/10.7759/cureus.26859 |
Ejemplares similares
-
Vanishing Adrenal Glands: Bilateral Adrenal Hemorrhage With Adrenal Insufficiency in COVID-19 Infection
por: Majety, Priyanka, et al.
Publicado: (2023) -
THU371 Empagliflozin Associated Pancreatitis: A Case Report
por: Poloju, Alekya, et al.
Publicado: (2023) -
Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis
por: Bandaru, Sindhura, et al.
Publicado: (2021) -
The Future of Cross-Continental Telemedicine in the Management of Complicated Endocrine Patients and Its Suitability Based on a Case Report
por: Khan, Zahid, et al.
Publicado: (2022) -
Sarcopenia and Endocrine Ageing: Are They Related?
por: Gupta, Prishita, et al.
Publicado: (2022)